Broad spectrum immune and antiviral gene modulation by oral...

Details Broad spectrum immune and antiviral gene modulation by oral... Broad spectrum immune and antiviral gene modulation by oral...

2007-06-18

2011-12-13

Saoud, Christine J (Department: 1646)

Drug, bio-affecting and body treating compositions

Lymphokine

Interferon

C424S085700, C514S001500, C514S003700

Reexamination Certificate

active

08075878

ABSTRACT:
An antiviral/immunomodulatory response in an animal is induced by oral administration to an infected animal, including humans, of a human α-interferon. Methods of conferring resistance or mitigating the effects of exposure to a virus including avian influenza are described.

REFERENCES:
patent: 4950652 (1990-08-01), Carter et al.
patent: 5019382 (1991-05-01), Cummins, Jr.
patent: 5910304 (1999-06-01), Cummins
patent: 6372218 (2002-04-01), Cummins
patent: 6509154 (2003-01-01), De Paillette
patent: 7339051 (2008-03-01), Crooke et al.
patent: 2005/0002901 (2005-01-01), Blatt
patent: 2005/0100885 (2005-05-01), Crooke et al.
patent: 2005/0137154 (2005-06-01), Carter et al.
patent: 2006/0024271 (2006-02-01), Alibek et al.
patent: 2006/0035859 (2006-02-01), Carter et al.
patent: 2007/0141080 (2007-06-01), Carter et al.
patent: 2008/0019943 (2008-01-01), Carter et al.
patent: 2009/0004141 (2009-01-01), Carter et al.
patent: 2004/013298 (2004-02-01), None
patent: 2004/092383 (2004-10-01), None
patent: 2005/009337 (2005-02-01), None
patent: 2005/019410 (2005-03-01), None
patent: 2006/082435 (2006-08-01), None
Kuiken et al, “Pathology of Human Influenza A (H5N1) . . . ”, Vet Pathol 40:304-310 (2003).
deJong et al, “Fatal Outcome of Human Influenza A (H5N1) . . . ”, Nature Medicine, Advance Online Publication; 2006.
Barnard et al. “Evaluation of immunomodulators, interferons and known in vitro SARS-coV inhibitors for inhibition of SARS-coV replication in BALB/c” Antiviral Chem. Chemother. 17:275-284 (2006).
Business Wire “Ampligen® enhances the effectiveness of Tamiflu against avian influenza: Second independent preclinical study confirms dsRNA increases flu vaccine effectiveness” two pages (Sep. 2005).
Business Wire “Hemispherx Biopharma expands evaluation of Alferon N against avian flu, promising effects in bird populations to be expanded based on WHO/UN findings” two pages (Feb. 2005).
D'Agostini et al. “Combination therapy with amantadine and immunomodulators potentiates antiviral effects in influenza a virus-infected mice” Antiviral Res. 20(suppl 1):160 (abstract 217) (Apr. 1993).
Dahl et al. “In vitro inhibition of SARS virus replication by human interferons” Scand. J. Infect. Dis. 36:829-831 (Dec. 2004).
Hayden et al. “Combined interferon-α2, rimantadine hydrochloride, and ribavirin inhibition of influenza virus replication in vitro” Antimicrobiol. Agents Chemother, 25:53-57 (Jan. 1984).
Houston Chronicle “Anti-virus drug relieves chronic fatigue syndrome” p. 20 (Oct. 1991).
Ison & Hayden “Therapeutic options for the management of influenza” Curr. Opin. Pharm. 1:482-490 (Oct. 2001).
Pharma Business Week “Avian influenza, Ampligen enhances the effectiveness of Tamiflu against avian influenza” p. 18 (Oct. 2005).
Subbarao & Roberts “Is there an ideal animal model for SARS?” Trends Microbiol. 14:299-303 (Jul. 2006).
Tan et al. “Inhibition of SARS coronavirus infection in vitro with clinically approved antiviral drugs” Emerging infect. Dis. 10:581-586 (Apr. 2004).
World Health Organization “Management of severe acute respiratory syndrome (SARS)” two pages (Nov. 2003).
Zhao et al. “Description and clinical treatment of an early outbreak of severe acute respiratory syndrome (SARS) in Guangzhou, PR China” J. Med. Microbiol. 52:715-720 (Aug. 2003).
Int'l Search Report and Preliminary Report on Patentability for PCT/US2007/005634 (Jun. 2008).
Extended search report (EESR) for related European Patent Application, Serial No. 07867004.9 mailed Sep. 14, 2009.
Office Action issued in connection with U.S. Appl. No. 11/713,097 mailed Jul. 23, 2009.
Shen, F., et al., “The immunomodulation and antiviral activity of human leucocyte interferon alpha orally administered in mice”, Chinese Journal of Biochemical Pharmaceutics, 2004, vol. 25, No. 3, pp. 141-143, including ABSTRACT, published Dec. 31, 2004.

Affiliated with

Also associated with

Rating

Broad spectrum immune and antiviral gene modulation by oral... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Broad spectrum immune and antiviral gene modulation by oral..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Broad spectrum immune and antiviral gene modulation by oral... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4258593